From a molecular drugstore viewpoint, Relafen 750, containing naproxen, represents a fascinating case study in drug action. Its main mechanism involves suppressing cyclooxygenase (COX) enzymes, specifically COX-2, which results in reduced production of inflammatory mediators . This specific inhibition reduces tenderness and discomfort associated wi